Neutrophil extracellular traps are increased after extracorporeal membrane oxygenation support initiation and present in thrombus: A preclinical study using sheep as an animal model. Issue 221 (January 2023)

• Record Type: Journal Article
• Authors: Zhang, Yang; Peng, Rui; Pei, Shengqiang; Gao, Sizhe; Sun, Yang; Cheng, Gaowa; Yu, Dongze; Wang, Ximing; Gao, Zhangwei; Ji, Bingyang; Zhou, Zhou
• Is Part Of: Thrombosis research. Issue 221(2023)
• Page Start: 173
• Page End: 182
• Publication Date: 2023-01
• Subjects: Neutrophil extracellular traps -- Extracorporeal membrane oxygenation -- Thrombosis and hemostasis; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2022.10.019
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Background: The balance between thrombosis and hemostasis is a difficult issue during extracorporeal membrane oxygenation (ECMO) support. The pathogenesis leading to thrombotic complications during ECMO support is not well understood. Neutrophil extracellular traps (NETs) were reported to participate in thrombosis and have a key role in inflammation. This study aimed to explore the role of NETs in thrombosis during ECMO support and investigate NETs as a predictive biomarker for thrombotic complications during ECMO assistance. Methods: Ten ovine models of ECMO support were established. Animals were then randomly divided into 2 groups (5 sheep/group): venoarterial (VA) ECMO group and venovenous (VV) ECMO group. The venous blood samples were collected at different time points. Markers of NETs were detected in plasma, neutrophils, and thrombi from the vessels and membrane. Moreover, circulating NETs levels in 8 adults treated in the intensive care unit (ICU) who received VA-ECMO and 8 healthy controls were detected; patient survival was also recorded. Results: In vivo study showed that neutrophils and NETs markers (dsDNA and citH3) levels were significantly elevated 6 h after ECMO compared to baseline. Isolated neutrophils from fresh blood at 6 h could release more NETs. dsDNA and citH3 levels were significantly higher in the VA mode than in the VV mode. NETs were found in thrombi from the vessel and membrane. Clinical data further revealed that dsDNA, citH3, and nucleosomes were higher in patients who received ECMO than in healthy controls. Conclusions: These data suggest NETs might be associated with thrombus during ECMO support, especially in the VA mode. These findings provide new insight into preventing thrombotic complications by targeting NETs. Also, NETs may potentially become an early warning biomarker for thrombosis under ECMO assistance.